相关实验视频

Updated: May 29, 2025

Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model

Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model

Published on: June 18, 2021

作为尼莫迪平在脑下出血中的辅助剂:一个元分析

Riva Satya Radiansyah¹, Yuri Pamungkas¹, Ilham Ikhtiar²

¹Faculty of Medicine and Health, Institut Teknologi Sepuluh Nopember, Surabaya, Indonesia.

Journal of Yeungnam medical science

|February 3, 2025

概括

将添加到尼莫迪平治疗副arachnoid出血 (SAH) 可能会减少大脑血管和延迟的大脑缺血症. 然而,这种组合并没有显著改善SAH患者的功能结果或死亡率.

科学领域:

神经学神经学
药理学药理学是指药理学的学科.

背景情况:

副arachnoid出血 (SAH) 呈现出显著的发病率和死亡率.
尼莫迪平是标准的SAH治疗,但辅助治疗的益处尚不清楚.
在SAH管理中作为尼莫迪平的辅助作用需要评估.

研究的目的:

评估将与尼莫迪平结合用于SAH的疗效和安全性.
为了确定的辅助治疗是否改善SAH患者的结果.

主要方法:

这是一项对12项涉及2338名患者的研究的元分析.
包括随机对照试验和前性队列研究.
比较加尼莫迪平与单独的尼莫迪平,分析大脑血管 (CV),延迟大脑缺血症 (DCI),功能结果,死亡率和不良事件.

主要成果:

加尼莫迪平显著降低了CV (OR,0.53;p=0.03) 和DCI (OR,0.52;p=0.01). 加尼莫迪平显著降低了CV (OR,0.53;p=0.03) 和DCI (OR,0.52;p=0.01).
在功能性结局 (mRS,GOS),死亡率或二次脑梗塞方面没有观察到显著差异.
组合组的不良事件发生率较高,但在统计学上不显著 (OR,3.14;p=0.33).

结论:

作为尼莫迪平补充剂的可能会降低SAH中的CV和DCI发病率.
这种组合并没有显著改善功能结果或死亡率.
需要进一步的大规模研究来证实这些发现并优化的剂量.

关键词:

大脑血管脑血管是的重要组成部分.死亡率死亡率死亡率尼莫迪平是尼莫迪平的一种药物.甲状腺下下垂体出血

更多相关视频

A Volumetric Method for Quantification of Cerebral Vasospasm in a Murine Model of Subarachnoid Hemorrhage

A Volumetric Method for Quantification of Cerebral Vasospasm in a Murine Model of Subarachnoid Hemorrhage

Published on: July 28, 2018

Biodegradable Magnesium Stent Treatment of Saccular Aneurysms in a Rat Model - Introduction of the Surgical Technique

Biodegradable Magnesium Stent Treatment of Saccular Aneurysms in a Rat Model - Introduction of the Surgical Technique

Published on: October 1, 2017

相关概念视频

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...

Antianginal Drugs: Nitrates and β-Blockers

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....

Drug Delivery: Enteral Route

Drug Delivery: Enteral Route

The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.